Drug Stocks Down on Safety Concerns
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
414238
Stocks inched lower on Friday,  pressured by a sharp drop in Pfizer Inc. PFE.N after the drug  maker said patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
488041
Foreign drug stocks were in the spotlight Thursday with Food and Drug Administration news pulling the sector down. AstraZeneca PLC took a drubbing on the eve of its FDA advisory panel meeting for its orally
520589
Investors are discouraged after it releases the latest data for its top drug.
291603
NEW YORK - Investors sent stocks lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
106101
U.S. stocks edged lower on Thursday,   dragged down by drug store shares after Wal-Mart Stores Inc.   WMT.N announced it was slashing prices of generic drugs in   Florida.
582328
Wall Street&#39;s holiday rally stumbled Monday, with stocks finishing mixed as investors worried over the strength of the pharmaceutical sector.
161543
Shares in pharmaceutical giants AstraZeneca PLC and GlaxoSmithKline PLC tumbled Friday after a US safety official raised concerns over key drugs sold by the companies.
271632
Pharmaceutical stocks were mixed in afternoon trading, performing slightly better than the Dow Jones Industrial Average but seeing sharp declines in smaller stocks on clinical trial snags.
172863
US stocks futures tumbled on Thursday after drug company Merck &amp; Co. (MRK.N: Quote, Profile, Research) announced it was recalling a key drug, indicating the market would open lower.
659659
Despite announcing the biggest news in its short history, OSI Pharmaceuticals stock fell nearly 10 percent Friday, as some investors grew nervous about whether its newly approved cancer drug would be the bonanza they expected.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
2126
Shares of large US and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of US regulators in monitoring drug safety.
323641
The share price of US drugs giant Merck falls to an eight-year low after it announces that it has been forced to withdraw a key drug on side effect fears.
318860
NEW YORK (CBS.MW) -- Merck (MRK) shares dipped almost 2 percent to $45.16, making it the biggest decliner in the Dow. The selling is related to just surfacing concerns about the safety of its Vioxx arthritis COX-2 inhibitor drug.
315772
Merck (MRK:NYSE - news - research) shares fell early Thursday after a study sponsored by the Food and Drug Administration concluded that its Vioxx arthritis drug put users at a greater risk to heart attacks than Pfizer&#39;s (PFE:NYSE - news - research